mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0003 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0003 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0003 |